Nanobiotix (NBTX) Common Equity (2020 - 2025)
Historic Common Equity for Nanobiotix (NBTX) over the last 6 years, with Q2 2025 value amounting to -$78.1 million.
- Nanobiotix's Common Equity fell 23281.99% to -$78.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$78.1 million, marking a year-over-year decrease of 23281.99%. This contributed to the annual value of -$71.1 million for FY2024, which is 346710.24% down from last year.
- Nanobiotix's Common Equity amounted to -$78.1 million in Q2 2025, which was down 23281.99% from -$70.2 million recorded in Q4 2024.
- In the past 5 years, Nanobiotix's Common Equity ranged from a high of $49.9 million in Q2 2021 and a low of -$78.1 million during Q2 2025
- Over the past 5 years, Nanobiotix's median Common Equity value was -$25.5 million (recorded in 2022), while the average stood at -$26.0 million.
- Per our database at Business Quant, Nanobiotix's Common Equity skyrocketed by 9281.34% in 2023 and then tumbled by 344072.11% in 2024.
- Over the past 5 years, Nanobiotix's Common Equity (Quarter) stood at $49.9 million in 2021, then plummeted by 155.3% to -$27.6 million in 2022, then soared by 92.81% to -$2.0 million in 2023, then plummeted by 3440.72% to -$70.2 million in 2024, then decreased by 11.17% to -$78.1 million in 2025.
- Its Common Equity stands at -$78.1 million for Q2 2025, versus -$70.2 million for Q4 2024 and -$23.5 million for Q2 2024.